Mauritius-based Aranda Investments is a foreign portfolio investor and a wholly-owned indirect subsidiary of Temasek Holdings (Private) Ltd, the investment arm of the Singapore government. Glenmark currently employs over 10,400 people in over 80 countries. It has 14 manufacturing facilities in four countries and has 6 R&D centres.
Besides, the Reserve Bank on Tuesday permitted foreign institutional investors (FIIs) to buy up to 49 percent stake in the homegrown drug major. The earlier limit was 40 percent. FIIs "through primary market and stock exchanges, can now purchase up to 49 percent of the paid up capital of Glenmark Pharmaceuticals Ltd under the Portfolio Investment Scheme (PIS)," the central bank said. Shares of Glenmark Pharmaceuticals on Tuesday closed at Rs 899.35 per scrip on BSE, down 0.71 per cent from it's previous close.

Latest News  from Business News Desk